About Apcegen
Apcegen is a company based in Bengaluru (India) founded in 2010 by Amita Vyas. Apcegen has raised $19.45 thousand across 2 funding rounds from investors including Indian Institute of Technology Kanpur and Department of Biotechnology. Apcegen operates in a competitive market with competitors including argenx, MacroGenics, Alexion, Zai Lab and Kodiak Sciences, among others.
- Headquarter Bengaluru, India
- Founders Amita Vyas
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Apcegen Technologies Private Limited
- Date of Incorporation 19 Apr, 2010
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$1.57 K (USD)0as on Mar 31, 2017
-
Net Profit
-$6.74 K (USD)0as on Mar 31, 2017
-
EBITDA
-$1.37 K (USD)0as on Mar 31, 2017
-
Total Equity Funding
$19.45 K (USD)
in 2 rounds
-
Latest Funding Round
$19.45 K (USD), Seed
Aug 12, 2015
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Apcegen
Apcegen has successfully raised a total of $19.45K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $19.45 thousand completed in August 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Apcegen
Apcegen has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Indian Institute of Technology Kanpur and Department of Biotechnology.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple engineering courses and degrees are offered at the institute.
|
Locked | Locked | Locked | |
|
Biotechnology research, guidelines, and funding by the Government of India.
|
Locked | Locked | Locked |
Investor details for Apcegen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Apcegen
Investment portfolio details for Apcegen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Apcegen
Detailed financials for Apcegen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Apcegen Comparisons
Peer comparison for Apcegen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Apcegen
Apcegen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as argenx, MacroGenics, Alexion, Zai Lab and Kodiak Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company focused on cancer therapeutics development.
|
|
| Locked | Locked | Locked |
Therapies for rare and devastating diseases are developed by Alexion.
|
|
| Locked | Locked | Locked |
Antibody-based therapies for cancers and inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for retinal diseases are developed by the company.
|
|
| Locked | Locked | Locked |
Antibody-based drugs for primary myopathies are developed and targeted.
|
Detailed competitors of Apcegen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Apcegen
Complete news archive for Apcegen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Apcegen
Apcegen was founded in 2010 and raised its 1st funding round 5 years after it was founded.
Apcegen is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Apcegen is a funded company, having raised a total of $19.45K across 2 funding rounds to date.
Annual revenue of Apcegen is $1.57K as on Mar 31, 2017.
Apcegen was founded in 2010 in Bengaluru, India, within the biotechnology sector. Peptide-based treatments for cancer and autoimmune conditions are developed by the company. Protein-based chips for diagnosing and treating diseases such as cancer-related anaemia, renal failure, and diabetes are also created. Operations focus on therapeutic innovations and diagnostic tools, with activities centered in India.
Apcegen's top competitors include argenx, Zai Lab and Kodiak Sciences.
Apcegen has 2 investors. Key investors include Indian Institute of Technology Kanpur, and Department of Biotechnology.
The valuation of Apcegen is $383.18K as of Aug 2015.